These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1446862

  • 1. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
    Lo SK, Fleming KA, Chapman RW.
    Gut; 1992 Oct; 33(10):1370-5. PubMed ID: 1446862
    [Abstract] [Full Text] [Related]

  • 2. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F.
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F, Slametschka D, Gregor M, Weber P.
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
    Haagsma EB, Mulder AH, Gouw AS, Horst G, Meerman L, Slooff MJ, Kallenberg CG.
    J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
    [Abstract] [Full Text] [Related]

  • 5. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Peña AS, Dolman KM, Bril H, Dekker W, Nauta JJ.
    Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
    [Abstract] [Full Text] [Related]

  • 6. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
    Peen E, Almer S, Bodemar G, Rydén BO, Sjölin C, Tejle K, Skogh T.
    Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
    [Abstract] [Full Text] [Related]

  • 7. Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?
    Lo SK, Chapman RW, Cheeseman P, Charlton CP, Walker-Smith JA, Mieli-Vergani G, Fleming KA.
    Gut; 1993 Feb; 34(2):199-202. PubMed ID: 8432473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH.
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
    Vidrich A, Lee J, James E, Cobb L, Targan S.
    J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CG.
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [Abstract] [Full Text] [Related]

  • 14. Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
    Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E.
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):575-80. PubMed ID: 9222729
    [Abstract] [Full Text] [Related]

  • 15. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
    Bansi DS, Fleming KA, Chapman RW.
    Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
    [Abstract] [Full Text] [Related]

  • 16. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
    Bansi D, Chapman R, Fleming K.
    J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
    Bansi DS, Lo S, Chapman RW, Fleming KA.
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T, Gerken G, Meyer Zum Büschenfelde KH, Mayet WJ.
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.